Stockreport

Immunovant price target lowered to $45 from $47 at Wells Fargo [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF Wells Fargo analyst Derek Archila lowered the firm's price target on Immunovant ( IMVT ) to $45 from $47 and keeps an Overweight rating on the shares. The firm adjusted [Read more]